Related Experiment Video
Updated: Jul 25, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Medicine. PPARs as therapeutic targets: reverse cardiology?
1Department of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. jplutzky@rics.bwh.harvard.edu
Abstract:
Formation of the atherosclerotic lesions that lead to myocardial infarction is determined in part by inflammatory responses such as the production of lipid-laden macrophages. In his Perspective, Plutzky highlights the parts played by PPAR nuclear receptors, especially PPAR-delta (Lee et al.), in the modulation of inflammatory responses and hence atherosclerosis.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pericarditis III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care

